GeneralConnection.com ➔ Dictionary
Dictionary Search

savara

Synonyms

Noun

1. Savara

2. Dravidian, Savara

3. South-Central Dravidian

Usage
Assessing Savara (SVRA) Valuation As A High Price To Book Meets Strong One Year Shareholder Returns - simplywall.st
Savara Announces Participation in the 2026 Jefferies Global Healthcare Conference - Business Wire
Savara Inc. (SVRA) Reports Q1 Financial Results - Yahoo Finance
FDA delays decision on Savara’s rare lung disease therapy to November - FirstWord Pharma
Savara Is On Xbox And PlayStation – And It Wants You To Earn Every Victory - TheXboxHub
FDA Extends Review of Savara’s Molgramostim BLA for PAP - BioPharm International
Savara: The Rare Disease Funnel Is Becoming A Commercial Asset (NASDAQ:SVRA) - Seeking Alpha
Savara (SVRA) Is Down 8.0% After FDA Grants Priority Review To MOLBREEVI - What's Changed - Yahoo Finance
Savara Announces Participation in 2026 Citizens Life Sciences Conference - Business Wire
Assessing Savara (SVRA) Valuation After FDA Extends Priority Review For Molgramostim - Yahoo Finance
Savara Announces the U.S. Food and Drug Administration (FDA) Filed the MOLBREEVI* Biologics License Application (BLA) in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP) - Business Wire
Savara Presented Long-Term Efficacy and Safety Data from the Ongoing IMPALA-2 Phase 3 Clinical Trial Open-Label (OL) Extension of Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) - Yahoo Finance
Savara To Present New Data at the American Thoracic Society (ATS) 2026 International Conference - Business Wire
Savara Presented New Biomarker Data from the IMPALA-2 Phase 3 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society (ATS) International Conference 20 - Yahoo Finance
Savara Announces the U.K. Medicines and Healthcare Products Regulatory Agency (MHRA) Has Accepted the MOLBREEVI* Marketing Authorisation Application (MAA) for Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP) - Business Wire
Savara Highlights FDA Priority Review for Molbreevi as Aug. 22 PDUFA Date Nears - Yahoo Finance
Savara Reports First Quarter Financial Results and Provides Business Update - Business Wire
Savara Announces Amendment to Hercules Capital Debt Facility Providing up to $75M of Additional Debt Funding Upon U.S. Food and Drug Administration (FDA) Approval of MOLBREEVI* - Yahoo Finance
Savara Provides Regulatory Update on the MOLBREEVI* Development Program in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP) - Yahoo Finance
Savara Reports Fourth Quarter and Year End 2025 Financial Results and Provides Business Update - Yahoo Finance
Savara, the colorful action roguelite launches Today on PlayStation 5 and Xbox Series X|S - Games Press
Savara Resubmits the Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for MOLBREEVI* for the Potential Treatment of Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP) - Yahoo Finance
Savara Eyes August PDUFA for MOLBREEVI as FDA BLA Filing Decision Nears, Execs Say at Summit - Yahoo Finance
Savara presents biomarker data from molgramostim trial at ATS - Investing.com
A Look At Savara (SVRA) Valuation After Positive Phase 3 IMPALA 2 Data And MOLBREEVI Launch Preparations - simplywall.st
Savara Announces New Employment Inducement Grant - Business Wire
Savara - official launch trailer - MSN
What Does Wall Street Think About Savara Inc. (SVRA)? - Yahoo Finance
New aPAP Phase 3 Data and Wider Losses Might Change The Case For Investing In Savara (SVRA) - simplywall.st
Savara’s FDA Review Extension Keeps Molgramostim Thesis Intact But Delayed - simplywall.st
SVRA: All proposals, including director elections and plan amendments, were approved - TradingView
SVRA: All proposals, including director elections and plan amendments, were approved - TradingView
Savara reports exercise improvements in aPAP drug trial - Investing.com
LifeSci Capital Maintains Savara(SVRA.US) With Buy Rating, Maintains Target Price $10 - Moomoo
Roguelite action game Savara coming to PS5, Xbox Series on May 20 - Gematsu
Lobbying Update: $30,000 of SAVARA INC. lobbying was just disclosed | SVRA Stock News - Quiver Quantitative
Action Roguelite Savara Launches On PlayStation 5 And Xbox Series X|S - The Otaku's Study
What Does the FDA's Priority Review Mean for Savara's MOLBREEVI - Kavout
Savara - Launch Trailer (PS5) - Gamereactor UK
Savara Stock: A High-Risk Opportunity (NASDAQ:SVRA) - Seeking Alpha
Savara Inc reports results for the quarter ended March 31 - Earnings Summary - TradingView
Savara [Trailers] - IGN
Savara presents 48-week data on molgramostim for rare lung disease - Investing.com
Jefferies reiterates Savara stock Buy rating on approval confidence - Investing.com
Savara Review (PS5) – Savara’Faire - fingerguns.net
FDA extends review of Savara’s molgramostim application - Investing.com
Guggenheim Reaffirms Their Buy Rating on Savara (SVRA) - The Globe and Mail
Savara gets FDA review extension for lead asset (SVRA:NASDAQ) - Seeking Alpha
Citizens reiterates Savara stock rating on regulatory progress - Investing.com
Savara - Official Launch Trailer - IGN India
Savara to present molgramostim data at ATS conference in May - Investing.com
Savara Has Finally Arrived on PlayStation 5 and Xbox Series X/S Today - COGconnected
Savara Combines Roguelite Progression And Soulslike Combat In A Colorful Fantasy World - Yahoo Tech
Savara receives European patent for PAP treatment device - Investing.com
Savara gets FDA review extension for lead asset - MSN
Savara presents 48-week data on molgramostim for rare lung disease By Investing.com - Investing.com South Africa
Savara 10-K: $0M Revenue, $0.00 EPS; $118.8M Net Loss - TradingView
BlackRock (SVRA holder) reports 5.4% ownership stake in Savara Inc. - Stock Titan
Langhorne, PA Biotech Eyes Mid-2026 Molbreevi Launch - Streetwise Reports
SVRA stock slips post-market after FDA delays decision on pulmonary therapy - MSN
Savara Promotes Dr. Yasmine Wasfi to Chief Medical Officer - Contract Pharma
Earnings Flash (SVRA) Savara Posts Q1 Per Share Loss $-0.15, vs. FactSet Est of $-0.13 Loss - marketscreener.com
Savara presents biomarker data from molgramostim trial at ATS By Investing.com - Investing.com South Africa
Savara Announces Participation in the H.C. Wainwright & Co. 4th Annual BioConnect Investor Conference - The Joplin Globe
Savara Inc. Confirms Participation in 2026 Citizens Life Sciences Conference Focused on Rare Respiratory Diseases - geneonline.com
Savara Promotes Yasmine Wasfi, M.D., Ph.D., FCCP To CMO - citybiz
Dumper rams BJP MP Hemant Savara’s car near Mumbai; driver suffers fracture - The Times of India
Savara (NASDAQ:SVRA) Strengthens Market Presence In Nasdaq Today Biotech Segment - Kalkine Media
Savara resubmits FDA application for potential treatment in rare lung disease patients - Indian Pharma Post
Savara faces earnings test ahead of crucial FDA decision By Investing.com - Investing.com South Africa
Savara Inc. Sees Price Target Raised Amid Promising Drug Developments - StocksToTrade
Levi & Korsinsky Notifies Savara Inc. (SVRA) Shareholders of Class Action Lawsuit and November 7, 2025 Deadline - ACCESS Newswire
Savara Inc stock (US80633A1025): respiratory disease specialist after latest clinical and funding up - AD HOC NEWS
Savara Inc stock (US80633A1025): fresh IMPALA?2 data at ATS 2026 keeps rare?disease bet in focus - AD HOC NEWS
Class Action Alert: Levi & Korsinsky Reminds Savara Inc. (SVRA) Investors of November 7, 2025 Deadline - ACCESS Newswire
Savara steps into Grammy spotlight with consideration in two categories - Citizen Digital
Kenya’s Savara Earns Grammy Consideration for Chart-Topping Tracks - KenyanVibe
Tribals fight to protect lands from encroachment in Andhra's Srikakulam - The New Indian Express
Savara Enters Into Non-Dilutive Debt Financing for up to $200M With Hercules Capital - Business Wire
FDA calls for additional manufacturing data in refusal letter for Savara's respiratory asset - Fierce Pharma
CHAN Final to attract star-studded music line-up including Eddy Kenzo, Zuchu and Savara at TotalEnergies CHAN, PAMOJA 2024, Closing Ceremony - Confédération Africaine de Football
Savara Inc stock (US80633A1025): Jefferies conference appearance keeps rare-disease biotech in focus - AD HOC NEWS
Savara (SVRA) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat
Evercore Downgrades Savara on Manufacturing Concerns for Lung Disease Drug Candidate - Yahoo Finance
Manufacturing issues scupper Savara's lead drug filing - pharmaphorum
Savara stock (US80633A1025): Rare disease biotech gains 3.74% on trading momentum - AD HOC NEWS
Savara, eyeing rare disease drug submission next year, nabs Orchard's commercial lead to steer launch - Fierce Pharma
Forest Rights Without Women's Rights: How FRA Delays Shape Tribal Women's Lives In Srikakulam - Feminism in India
Savara Announces Pricing of $100.0 Million Underwritten Offering of Common Stock - Business Wire
Savara completes patient enrolment in trial of lung disease therapy - Clinical Trials Arena
Savara sponsors Lifetime talk show episode about rare respiratory disease ahead of FDA submission - Fierce Pharma
Parvathipuram’s Unique Temple, Where Letters Are Worshipped - Deccan Chronicle
Savara to Present New Data from the Phase 3 IMPALA-2 Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients with Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the European Respiratory Society Congress 2025 - DutchNews.nl
Savara Completes Submission of the Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for MOLBREEVI* as a Treatment for Autoimmune Pulmonary Alveolar Proteinosis (aPAP) - BioSpace
Savara sets executive bonus targets for 2025 - Investing.com
Nviiri and Savara's date – Sol Family - dstv.com
Savara: Loan & Security Agreement Signed For Up To $200 Million With Hercules Capital - Pulse 2.0
Savara Inc ends sales agreement with Evercore - Investing.com
Bien, Savara to join Pan-African stars at Africa Le Forward concert - KBC Digital
Try Out Maliki: Poison of the Past & Savara at Steam Next Fest - GameSpace.com
Foreign Language Equivalents
Foreign Language Equivalents of 'savara'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
savar,   ssvara,   svara,   savarra,   svaara,   savsra,   saavara,   saavra,   savvara,   savaraa,   savra,   savata,   savaar,   savaa,   avara,   sabara,   saara,   asvara,   savaea,   sacara,   ssavara,   savars,   savaara,   savraa,   aavara,   davara
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z